SEC Form 4 · accession 0000899243-17-020410
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanofi
10% Owner
Period of report
Aug 14, 2017
Accepted (ET)
Aug 16, 2017 · 7:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock Par value per share $ 0.0001 | Aug 14, 2017 | P | 350,000 | $35.50 | A | 4,018,899 | I | Via wholly owned subsidiary Aventis Inc. |
Table II — derivative securities
No Table II lines on this filing.